Lista de obras - Pieter Jelle Visser - Dominio Público Uruguay

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

artículo científico publicado en 2014

A framework for assessing neuropsychiatric phenotypes by using smartphone-based location data

artículo científico publicado en 2020

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

artículo científico publicado en 2020

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project

artículo científico publicado en 2020

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

scholarly article by Mara ten Kate et al published July 2016 in Alzheimer's and Dementia

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

scholarly article by Mara ten Kate et al published July 2016 in Alzheimer's and Dementia

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal.

artículo científico publicado en 2019

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

artículo científico publicado en 2017

Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease

artículo científico publicado en 2015

Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

scholarly article by Lyduine Collij et al published 12 October 2018 in The Journal of Nuclear Medicine

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

artículo científico publicado en 2017

Association of amyloid pathology with memory performance and cognitive complaints in cognitively normal older adults: a monozygotic twin study

artículo científico publicado en 2019

Atrophy in the parahippocampal gyrus as an early biomarker of Alzheimer’s disease ⬇️

artículo científico publicado el 19 de octubre de 2010

Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline

artículo científico publicado en 2018

Author Correction: Heritability estimates for 361 blood metabolites across 40 genome-wide association studies

artículo científico publicado en 2020

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease

artículo científico publicado en 2019

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

scientific article published on 13 September 2019

Biomarkers for Alzheimer's disease: a controversial topic

artículo científico publicado en 2015

CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

article by Mara ten Kate et al published July 2017 in Alzheimer's and Dementia

CSF AMYLOID BETA 1-42 LEVELS OBTAINED OVER 15 YEARS SHOW A DIAGNOSIS-DEPENDENT UPWARD DRIFT

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

artículo científico publicado en 2009

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

artículo científico publicado en 2012

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

artículo científico publicado en 2017

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

artículo científico publicado en 2014

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

artículo científico publicado en 2019

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease

artículo científico publicado en 2022

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease

artículo científico publicado en 2020

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

artículo científico publicado en 2017

Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

artículo científico publicado en 2017

Cognitive functioning of individuals aged 90 years and older without dementia: A systematic review

artículo científico publicado en 2017

Consensus guidelines for lumbar puncture in patients with neurological diseases

artículo científico publicado en 2017

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.

artículo científico publicado en 2018

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

artículo científico publicado en 2017

DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION

scholarly article by Sarah Westwood et al published July 2017 in Alzheimer's and Dementia

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

scholarly article by Rosha Babapour Mofrad et al published December 2019 in Alzheimer's & dementia (Amsterdam, Netherlands)

Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid

scientific article published on 24 March 2020

Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia

scientific article published on 23 October 2019

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

artículo científico publicado en 2019

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

artículo científico publicado en 2020

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

artículo científico publicado en 2019

Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change

scholarly article by Lianne M. Reus et al published September 2018 in Journal of Psychiatric Research

Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study

artículo científico publicado en 2011

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

scientific article published on 01 June 2019

Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers

artículo científico publicado en 2016

European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.

artículo científico publicado en 2018

Functional and effective whole brain connectivity using magnetoencephalography to identify monozygotic twin pairs.

artículo científico publicado en 2017

Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease

artículo científico publicado en 2015

Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

artículo científico publicado en 2020

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults.

artículo científico publicado en 2018

Gray matter network disruptions and amyloid beta in cognitively normal adults

artículo científico publicado en 2015

Grey matter network disruptions are related to amyloid beta in cognitively healthy elderly

article by Betty M Tijms et al published July 2015 in Alzheimer's and Dementia

Grey matter network disruptions are related to amyloid-beta in cognitively healthy elderly

article by Betty M Tijms et al published July 2015 in Alzheimer's and Dementia

Heritability estimates for 361 blood metabolites across 40 genome-wide association studies

artículo científico publicado en 2020

Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

artículo científico publicado en 2015

Impact of ApoE-Ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

article by Mara ten Kate et al published July 2015 in Alzheimer's and Dementia

Impact of ApoE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

article by Mara ten Kate et al published July 2015 in Alzheimer's and Dementia

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

artículo científico publicado en 2017

Inflammatory biomarkers in Alzheimer's disease plasma.

artículo científico publicado en 2019

Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease

artículo científico publicado en 2014

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease

artículo científico publicado en 2012

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

artículo científico publicado en 2012

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly

artículo científico publicado en 2015

Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study

artículo científico publicado en 2015

Low normal cerebrospinal fluid Aβ42 levels predict clinical progression in nondemented subjects

artículo científico publicado en 2017

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

scholarly article by Mara Ten Kate et al published 27 September 2018 in Alzheimers Research & Therapy

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment

artículo científico publicado en 2013

Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study

artículo científico publicado en 2017

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease

scholarly article by Ellen Dicks et al published 2019 in NeuroImage: Clinical

Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index

artículo científico publicado en 2017

Multi-tracer model for staging cortical amyloid deposition using PET imaging

artículo científico publicado en 2020

NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers

artículo científico publicado en 2016

Optical coherence tomography angiography in preclinical Alzheimer's disease

scientific article published on 22 May 2019

Optimizing patient care and research: the Amsterdam Dementia Cohort

artículo científico publicado en 2014

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

scientific article published on 28 November 2019

Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals

scholarly article by Betty M Tijms et al published September 2018 in Annals of clinical and translational neurology

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

artículo científico publicado en 2013

Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers

artículo científico publicado en 2017

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

artículo científico publicado en 2013

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

artículo científico publicado en 2020

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage

artículo científico publicado en 2015

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

artículo científico publicado en 2009

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis

artículo científico publicado en 2015

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

artículo científico publicado en 2018

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

artículo científico publicado en 2015

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

artículo científico publicado en 2018

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

scientific article published on 08 May 2019

Progression to dementia in memory clinic patients without dementia: a latent profile analysis

artículo científico publicado en 2013

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

artículo científico publicado en 2016

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

artículo científico publicado en 2016

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

artículo científico publicado en 2012

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition

artículo científico publicado en 2017

Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study

Retinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions

artículo científico publicado en 2018

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

artículo científico publicado en 2019

Secondary prevention of Alzheimer's dementia: neuroimaging contributions

artículo científico publicado en 2018

Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study

artículo científico publicado en 2013

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease

scientific article published on 15 July 2020

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

artículo científico publicado en 2017

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia

artículo científico publicado en 2018

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

artículo científico publicado en 2011

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

artículo científico publicado en 2012

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

artículo científico publicado en 2015

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.

artículo científico publicado en 2018

The EMIF-AD PreclinAD study: study design and baseline cohort overview

article by Elles Konijnenberg et al published 4 August 2018 in Alzheimers Research & Therapy

The Effect of Psychological Distress and Personality Traits on Cognitive Performances and the Risk of Dementia in Patients with Mild Cognitive Impairment

artículo científico publicado en 2015

The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community

scientific article published on 07 May 2019

The association of vascular disorders with incident dementia in different age groups

scientific article published on 17 May 2019

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

artículo científico publicado en 2014

The frequency and influence of dementia risk factors in prodromal Alzheimer's disease

artículo científico publicado en 2017

The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group

artículo científico publicado en 2017

The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey

artículo científico publicado en 2014

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity

artículo científico publicado en 2019

Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results

artículo científico publicado en 2017

Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population

artículo científico publicado en 2017

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey

scientific article published on 22 August 2019

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

scientific article published on 01 January 2020

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice

artículos científicos

Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease

scientific article published on 01 August 2019

What determines cognitive functioning in the oldest-old? The EMIF-AD 90+ Study

artículo científico publicado en 2020

White matter hyperintensities and vascular risk factors in monozygotic twins.

artículo científico publicado en 2018

White matter microstructure disruption in early stage amyloid pathology

artículo científico publicado en 2021

Lista de obras de Pieter Jelle Visser

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

A framework for assessing neuropsychiatric phenotypes by using smartphone-based location data

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal.

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease

Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

Association of amyloid pathology with memory performance and cognitive complaints in cognitively normal older adults: a monozygotic twin study

Atrophy in the parahippocampal gyrus as an early biomarker of Alzheimer’s disease ⬇️

Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline

Author Correction: Heritability estimates for 361 blood metabolites across 40 genome-wide association studies

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

Biomarkers for Alzheimer's disease: a controversial topic

CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

CSF AMYLOID BETA 1-42 LEVELS OBTAINED OVER 15 YEARS SHOW A DIAGNOSIS-DEPENDENT UPWARD DRIFT

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Cognitive functioning of individuals aged 90 years and older without dementia: A systematic review

Consensus guidelines for lumbar puncture in patients with neurological diseases

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid

Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change

Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers

European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.

Functional and effective whole brain connectivity using magnetoencephalography to identify monozygotic twin pairs.

Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease

Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults.

Gray matter network disruptions and amyloid beta in cognitively normal adults

Grey matter network disruptions are related to amyloid beta in cognitively healthy elderly

Grey matter network disruptions are related to amyloid-beta in cognitively healthy elderly

Heritability estimates for 361 blood metabolites across 40 genome-wide association studies

Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

Impact of ApoE-Ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

Impact of ApoE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

Inflammatory biomarkers in Alzheimer's disease plasma.

Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly

Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study

Low normal cerebrospinal fluid Aβ42 levels predict clinical progression in nondemented subjects

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment

Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease

Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index

Multi-tracer model for staging cortical amyloid deposition using PET imaging

NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers

Optical coherence tomography angiography in preclinical Alzheimer's disease

Optimizing patient care and research: the Amsterdam Dementia Cohort

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.